Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells 12,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total value of $214,080.00. Following the completion of the sale, the insider directly owned 160,230 shares of the company’s stock, valued at approximately $2,858,503.20. The trade was a 6.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alignment Healthcare Stock Performance

Shares of ALHC stock traded down $0.03 during trading on Thursday, reaching $18.16. 3,987,587 shares of the company’s stock were exchanged, compared to its average volume of 2,967,147. Alignment Healthcare, Inc. has a twelve month low of $11.63 and a twelve month high of $23.87. The firm’s fifty day moving average price is $20.57 and its 200-day moving average price is $18.78. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The stock has a market capitalization of $3.71 billion, a PE ratio of -1,814.19, a PEG ratio of 2.62 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the firm posted ($0.16) EPS. The company’s quarterly revenue was up 44.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

Several analysts recently commented on the stock. TD Cowen lifted their target price on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a report on Friday, January 16th. UBS Group increased their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a report on Wednesday, January 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. Robert W. Baird set a $28.00 price objective on Alignment Healthcare in a report on Friday, January 30th. Finally, JPMorgan Chase & Co. increased their target price on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $24.56.

Institutional Trading of Alignment Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of ALHC. Teacher Retirement System of Texas increased its holdings in Alignment Healthcare by 85.8% in the third quarter. Teacher Retirement System of Texas now owns 102,827 shares of the company’s stock valued at $1,794,000 after purchasing an additional 47,472 shares during the period. Y Intercept Hong Kong Ltd acquired a new stake in shares of Alignment Healthcare in the third quarter valued at about $3,499,000. Inspire Investing LLC bought a new position in shares of Alignment Healthcare during the third quarter worth about $1,129,000. Cinctive Capital Management LP bought a new position in shares of Alignment Healthcare during the third quarter worth about $3,814,000. Finally, Ameritas Investment Partners Inc. lifted its stake in shares of Alignment Healthcare by 32.9% in the second quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after acquiring an additional 3,225 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.